AllPennyStocks.com Biotech Stock Surges To Close The Week After Major Announcement

Biotech Stock Surges To Close The Week After Major Announcement

Biotech Stock Surges To Close The Week After Major Announcement By: Tomas Ronolski - AllPennyStocks.com News

Friday, May 23, 2025

A New Jersey-based biotech company stole the show to finish out the week after the company announced new data from its Phase 2 OVATION 2 study of IMNN-001. This news just came one day following the company’s request for withdrawal with the SEC for its Form S-1. 

Traders rushed to buy up shares of Imunon Inc. (Nasdaq:IMNN), pushing the micro cap to close the session up at $1.16/share (+179.18%). This move was a strong comeback from this month’s drop off in share price. 

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.


Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

An EdTech Company's $44.6 Million Pivot Into AI's Hottest Corner
Billion-Dollar PEA Ignites Rally in Junior Gold Stock
Major Miner Takes Stake in Junior Explorer, Sending Shares Up More Than 25%
Most Popular
{{ index + 1 }}
AllPennyStocks.com Favorites


Back to Top